JNJ vs META: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and Meta Platforms, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
VS
Meta Platforms, Inc. · Communication Services
$665.60
+21.4% upside to fair value
Med Conviction
Grade B+
High Quality
QuantHub Verdict
META has more upside to fair value
(+21.4%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
META |
| Current Price |
$270.68 |
$665.60 |
| Fair Value Estimate |
$286.05 |
$808.00 |
| Upside to Fair Value |
+5.7%
|
+21.4%
|
| Market Cap |
$652.3B |
$1,695.6B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
20.2x
|
16.7x
|
| Price / Sales |
6.7x
|
7.4x
|
| Price / FCF |
35.3x
|
41.3x
|
| Revenue Growth YoY |
+6.6%
|
+28.0%
|
| Gross Margin |
67.9%
|
81.7%
|
| Operating Margin |
26.8%
|
38.1%
|
| Return on Equity |
25.7%
|
29.7%
|
| Dividend Yield |
1.95% |
0.32% |
| FCF Yield |
2.83%
|
2.42%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
Meta Platforms operates the Facebook, Instagram, WhatsApp, Messenger and Threads ecosystem, monetizing its unmatched global audience primarily through digital advertising. Business quality is high, supported by 3.60 billion Family daily active people, AI-enhanced ad ranking, 81.7% TTM gross margin, 38.1% TTM operating margin, 29.8% TTM net margin and 29.7% ROE. Revenue grew 28.0% year over year i…
Accumulation Zones
| Metric |
JNJ |
META |
| Zone Low |
$214.54 |
$606.00 |
| Zone High |
$243.14 |
$686.80 |
| In Buy Zone? |
No
|
Yes
|